Sign in

CIK 0001680048

  • Non-accelerated filer
  • Smaller reporting company

MUSTANG BIO, INC.

Sign in to watch
Ticker
MBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473828760
Phone
+1 781-652-4500
Business address
95 SAWYER RD, SUITE 110, WALTHAM, MA, 02453
  1. 4 Grant or award Director acquired 7,246 shares (grant or award)
  2. 4 Grant or award President and CEO acquired 5,000 shares (grant or award)
  3. 3/A Insider 3/A
  4. 3/A Insider 3/A
  5. 4 Open-market buy Director bought 10,000 shares at an average $0.63 ($6,277)
  6. 4 Open-market buy Director bought 9,094 shares at an average $0.62 ($5,607)
  7. 4 Grant or award Director acquired 71,664 shares (grant or award)
  8. 4 Grant or award Director acquired 71,664 shares (grant or award)
  9. 4 Grant or award Director acquired 71,664 shares (grant or award)
  10. 4 Grant or award Director acquired 71,664 shares (grant or award)
  11. 4 Grant or award 10% owner acquired 2,807,008 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale SVP, Fin. & Corp. Controller sold 4,374 shares at $1.83 ($8,004)
  14. 4 Open-market buy President and CEO bought 65,000 shares at $2.24 ($145,600)
  15. 4 Open-market sale SVP, Fin. & Corp. Controller sold 4,450 shares at $2.28 ($10,146)
  16. 4 Grant or award Director acquired 1,170 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 2,746 shares (grant or award)
  18. 4 Open-market buy President and CEO bought 86,206 shares at $2.91 ($250,859)
  19. 4 Grant or award Director acquired 13,774 shares (grant or award)
  20. 4 Grant or award Director acquired 13,774 shares (grant or award)

Page 2 of 5 · 85 filings